Novo Nordisks Wegovy cuts risk of heart attack and stroke by 20 ... - Morningstar
| NOVO-B Stock | DKK 757.30 9.70 1.30% |
About 50% of Novo Nordisk's investors are presently thinking to get in. The analysis of current outlook of investing in Novo Nordisk AS suggests that some traders are interested regarding Novo Nordisk's prospects. The current market sentiment, together with Novo Nordisk's historical and current headlines, can help investors time the market. In addition, many technical investors use Novo Nordisk AS stock news signals to limit their universe of possible portfolio assets.
Novo |
Novo Nordisks Wegovy cuts risk of heart attack and stroke by 20 ... Morningstar
Read at news.google.com
 |
Novo Nordisk Fundamental Analysis
We analyze Novo Nordisk's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Novo Nordisk using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Novo Nordisk based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Novo Nordisk is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Novo Nordisk AS Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Novo Nordisk stock to make a market-neutral strategy. Peer analysis of Novo Nordisk could also be used in its relative valuation, which is a method of valuing Novo Nordisk by comparing valuation metrics with similar companies.
Peers
Novo Nordisk Related Equities
| VWS | Vestas Wind | 1.67 | ||||
| DSV | DSV Panalpina | 1.24 | ||||
| DANSKE | Danske Bank | 0.75 | ||||
| BAVA | Bavarian Nordic | 0.05 | ||||
| ORSTED | Orsted AS | 0.91 |
Complementary Tools for Novo Stock analysis
When running Novo Nordisk's price analysis, check to measure Novo Nordisk's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novo Nordisk is operating at the current time. Most of Novo Nordisk's value examination focuses on studying past and present price action to predict the probability of Novo Nordisk's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novo Nordisk's price. Additionally, you may evaluate how the addition of Novo Nordisk to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |